Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeNovavax

      Novavax

      Novavax Faces FDA Setback
      Market News

      Novavax Faces FDA Setback

      October 17, 2024
      Novavax Stock Soars Nearly 300% in One Month
      Investing News

      Novavax Stock Soars Nearly 300% in One Month

      June 7, 2024
      Novavax Faces Uphill Battle, Forecasts Flat to Lower Sales in 2024
      Investing News

      Novavax Faces Uphill Battle, Forecasts Flat to Lower Sales in 2024

      February 28, 2024
      Novavax Surpasses Revenue Estimates, Eyes Further Cost Reductions
      Investing News

      Novavax Surpasses Revenue Estimates, Eyes Further Cost Reductions

      November 9, 2023
      Novavax Expands Its Vaccine Portfolio Amidst Evolving Landscape
      Investing News

      Novavax Expands Its Vaccine Portfolio Amidst Evolving Landscape

      October 10, 2023
      Is It Too Late to Invest in Novavax Stock?
      Investing News

      Is It Too Late to Invest in Novavax Stock?

      October 20, 2022
      Novavax Stock: Explaining Wednesday’s Decline
      Investing News

      Novavax Stock: Explaining Wednesday’s Decline

      October 19, 2022
      Novavax Stock Remains a Risk-on Stock in a Risk-off Market
      Investing News

      Novavax Stock Remains a Risk-on Stock in a Risk-off Market

      September 22, 2022
      Novavax Developed COVID-19 Vaccine Has Been Approved by The Swiss Government 
      Investing News

      Novavax Developed COVID-19 Vaccine Has Been Approved by The Swiss Government 

      September 5, 2022
      Novavax Experiences a 52-Week Low as Pfizer and Moderna Receive FDA Approval for Improved Boosters
      Investing News

      Novavax Experiences a 52-Week Low as Pfizer and Moderna Receive FDA Approval for Improved Boosters

      August 31, 2022
      1 2 »

       

      LATEST NEWS

      • Investing News Beta Technologies Q3 IPO Insights
      • Investing News Salesforce Reports Robust Q3 2026 Earnings
      • Investing News Salesforce’s Stock Boost Amid Raised Guidance
      • Investing News Macy’s Q3 2025 Earnings Overview
      • Investing News Okta’s Strong Q3 2026 Earnings Boost Shares

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025